| 1 |
32181582 | MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway. | 2020 Apr |
2 |
| 2 |
32848856 | Role of NKCC1 Activity in Glioma K+ Homeostasis and Cell Growth: New Insights With the Bumetanide-Derivative STS66. | 2020 |
2 |
| 3 |
32960603 | Cedrol, a Sesquiterpene Alcohol, Enhances the Anticancer Efficacy of Temozolomide in Attenuating Drug Resistance via Regulation of the DNA Damage Response and MGMT Expression. | 2020 Oct 23 |
1 |
| 4 |
31146105 | LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition. | 2019 Aug |
1 |
| 5 |
31540977 | Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide. | 2019 Dec 15 |
1 |
| 6 |
29779087 | Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model. | 2018 Sep |
1 |
| 7 |
23384836 | Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice. | 2013 Mar |
2 |
| 8 |
23699535 | TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance. | 2013 Aug |
2 |